Reckitt Benckiser Group (LON:RB) was upgraded by investment analysts at UBS Group to a “buy” rating in a research note issued on Monday, Borsen Zeitung reports. The firm currently has a GBX 8,400 ($103.37) price objective on the stock, up from their previous price objective of GBX 5,700 ($70.15). UBS Group’s price target points to a potential upside of 13.02% from the stock’s current price.

Several other research firms have also recently weighed in on RB. Citigroup reissued a “buy” rating on shares of Reckitt Benckiser Group in a report on Thursday, June 18th. Royal Bank of Canada set a GBX 4,900 ($60.30) target price on shares of Reckitt Benckiser Group and gave the stock a “sell” rating in a research report on Friday, June 5th. HSBC set a GBX 7,300 ($89.84) target price on shares of Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Morgan Stanley restated an “overweight” rating and set a GBX 7,000 ($86.14) target price on shares of Reckitt Benckiser Group in a research report on Monday, May 18th. Finally, CSFB restated a “neutral” rating on shares of Reckitt Benckiser Group in a research report on Thursday, April 30th. Two analysts have rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of GBX 7,117.37 ($87.59).

Reckitt Benckiser Group stock opened at GBX 7,432 ($91.46) on Monday. The stock has a market cap of $52.69 billion and a P/E ratio of -14.28. The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80. Reckitt Benckiser Group has a twelve month low of GBX 5,130 ($63.13) and a twelve month high of GBX 8,191.30 ($100.80). The company’s 50-day moving average price is GBX 7,055.16 and its two-hundred day moving average price is GBX 6,393.24.

In related news, insider Nicandro Durante bought 165 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were purchased at an average price of GBX 6,884 ($84.72) per share, for a total transaction of £11,358.60 ($13,978.10).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading: How prevalent are 12b-1 fees?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.